EFFICACY AND SAFETY IN THE USE OF ROMOSOZUMAB IN POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS AT HIGH RISK OF FRACTURE IN AN OUTPATIENT CASE SERIES FROM THE MARCHE REGION

被引：0
|
作者：
Farina, A. [1 ]
Pingiotti, E. [1 ]
Martino, G. P. [1 ]
Bitti, G. [1 ]
Angelici, S. [1 ]
机构：
[1] Osped Civile A Murri, Internal Med, Fermo, Italy
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2024年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P147
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada
    Goeree, Ron
    Burke, Natasha
    Jobin, Manon
    Brown, Jacques P.
    Lawrence, Donna
    Stollenwerk, Bjorn
    Willems, Damon
    Johnson, Ben
    ARCHIVES OF OSTEOPOROSIS, 2022, 17 (01)
  • [22] Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada
    Ron Goeree
    Natasha Burke
    Manon Jobin
    Jacques P. Brown
    Donna Lawrence
    Björn Stollenwerk
    Damon Willems
    Ben Johnson
    Archives of Osteoporosis, 2022, 17
  • [23] RISK FACTORS FOR POSTMENOPAUSAL OSTEOPOROSIS IN BOSNIAN WOMEN: CASE SERIES STUDY
    Sokolovic, S.
    Alimanovic-Alagic, R.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S258 - S258
  • [24] T-Score As an Indicator of Fracture Risk on Therapy: Evidence from Romosozumab Vs Alendronate Treatment in the Active-Controlled Fracture Study in Postmenopausal Women with Osteoporosis at High Risk Trial
    Cosman, Felicia
    Lewiecki, E. Michael
    Ebeling, Peter R.
    Hesse, Eric
    Napoli, Nicola
    Crittenden, Daria B.
    Rojeski, Maria
    Yang, Wenjing
    Libanati, Cesar
    Ferrari, Serge
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [25] Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study
    Baek, Ki-Hyun
    Chung, Yoon-Sok
    Koh, Jung-Min
    Kim, In Joo
    Kim, Kyoung Min
    Min, Yong-Ki
    Park, Ki Deok
    Dinavahi, Rajani
    Maddox, Judy
    Yang, Wenjing
    Kim, Sooa
    Lee, Sang Jin
    Cho, Hyungjin
    Lim, Sung-Kil
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (01) : 60 - 69
  • [26] Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
    Devogelaer, J. P.
    Roux, C.
    Isaia, G.
    Andia, J. B. Cannata
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S335 - S335
  • [27] Clinical and nonvertebral fracture risk is reduced with the use of ibandronate in women with postmenopausal osteoporosis
    Miller, P. D.
    Harris, S. T.
    Blumentals, W. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S451 - S451
  • [28] Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
    Roux, C.
    Isaia, G.
    Andia, J. B. Cannata
    Devogelaer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 681 - 681
  • [29] Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
    Roux, C.
    Fechtenbaum, J.
    Kolta, S.
    Isaia, G.
    Andia, J. B. Cannata
    Devogelaer, J-P
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) : 1736 - 1738
  • [30] T-SCORE AS AN INDICATOR OF FRACTURE RISK ON THERAPY: EVIDENCE FROM ROMOSOZUMAB VS. ALENDRONATE TREATMENT IN THE ACTIVE-CONTROLLED FRACTURE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AT HIGH RISK TRIAL
    Cosman, F.
    Lewiecki, E. M.
    Ebeling, P. R.
    Hesse, E.
    Napoli, N.
    Crittenden, D. B.
    Rojeski, M.
    Yang, W.
    Libanati, C.
    Ferrari, S. L.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S168 - S168
12345